I'm LongbridgeAI, I can summarize articles.In a report released today, David Bailey from Morgan Stanley maintained a Buy rating on Integral Diagnostics Ltd., with a price target of A$3.70. According to TipRanks, Bailey is a 4-star analyst with an average return of 9.4% and a 52.63% success rate. Bailey covers the Healthcare sector, focusing on stocks such as Integral Diagnostics Ltd., Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh, and Resmed. Integral Diagnostics Ltd. has an analyst consensus of Strong Buy, with a price target consensus of A$3.14.
In a report released today, David Bailey from Morgan Stanley maintained a Buy rating on Integral Diagnostics Ltd., with a price target of A$3.70.
According to TipRanks, Bailey is a 4-star analyst with an average return of 9.4% and a 52.63% success rate. Bailey covers the Healthcare sector, focusing on stocks such as Integral Diagnostics Ltd., Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh, and Resmed.
Integral Diagnostics Ltd. has an analyst consensus of Strong Buy, with a price target consensus of A$3.14.